Detalhe da pesquisa
1.
A complete oral regimen for induction therapy of patients with high-risk APL: An oral etoposide instead of intravenous infusion for cytoreductive chemotherapy.
Br J Haematol
; 2024 Apr 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38671583
2.
Usefulness of KIT mutant transcript levels for monitoring measurable residual disease in t (8;21) acute myeloid leukemia.
Hematol Oncol
; 42(2): e3264, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38461410
3.
ZNF384 fusion transcript levels for measurable residual disease monitoring in adult B-cell acute lymphoblastic leukemia.
Hematol Oncol
; 42(1): e3251, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38287528
4.
Monitoring of post-transplant MLL-PTD as minimal residual disease can predict relapse after allogeneic HSCT in patients with acute myeloid leukemia and myelodysplastic syndrome.
BMC Cancer
; 22(1): 11, 2022 Jan 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34979982
5.
Combination of KIT and FLT3-ITD mutation status with minimal residual disease levels guides treatment strategy for adult patients with inv(16) acute myeloid leukemia in first complete remission.
Hematol Oncol
; 40(4): 724-733, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35531760
6.
Low EVI1 expression at diagnosis predicted poor outcomes in pediatric Ph-negative B cell precursor acute lymphoblastic leukemia patients.
Pediatr Hematol Oncol
; 39(2): 97-107, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34156313
7.
PML-RARA transcript levels at the end of induction therapy are associated with prognosis in non-high-risk acute promyelocytic leukaemia with all-trans retinoic acid plus arsenic in front-line therapy: long-term follow-up of a single-centre cohort study.
Br J Haematol
; 195(5): 722-730, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34405393
8.
Wilms' tumor gene 1 is an independent prognostic factor for pediatric acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation.
BMC Cancer
; 21(1): 292, 2021 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-33740924
9.
Profiles of NK cell subsets are associated with successful tyrosine kinase inhibitor discontinuation in chronic myeloid leukemia and changes following interferon treatment.
Ann Hematol
; 100(10): 2557-2566, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34278524
10.
Minimal residual disease monitoring and preemptive immunotherapies for frequent 11q23 rearranged acute leukemia after allogeneic hematopoietic stem cell transplantation.
Ann Hematol
; 100(5): 1267-1281, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33712867
11.
DPEP1 expression promotes proliferation and survival of leukaemia cells and correlates with relapse in adults with common B cell acute lymphoblastic leukaemia.
Br J Haematol
; 190(1): 67-78, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32068254
12.
Overexpressed WT1 exhibits a specific immunophenotype in intermediate and poor cytogenetic risk acute myeloid leukemia.
Ann Hematol
; 99(2): 215-221, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31900500
13.
The predictive value of minimal residual disease when facing the inconsistent results detected by real-time quantitative PCR and flow cytometry in NPM1-mutated acute myeloid leukemia.
Ann Hematol
; 99(1): 73-82, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31768677
14.
S100A16 suppresses the growth and survival of leukaemia cells and correlates with relapse and relapse free survival in adults with Philadelphia chromosome-negative B-cell acute lymphoblastic leukaemia.
Br J Haematol
; 185(5): 836-851, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30916375
15.
The prognostic significance of Wilms' tumor gene 1 (WT1) expression at diagnosis in adults with Ph-negative B cell precursor acute lymphoblastic leukemia.
Ann Hematol
; 98(11): 2551-2559, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31493003
16.
Incidence, risk factors and outcomes of sinusoidal obstruction syndrome after haploidentical allogeneic stem cell transplantation.
Ann Hematol
; 98(7): 1733-1742, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-31053879
17.
Outcome and Minimal Residual Disease Monitoring in Patients with t(16;21) Acute Myelogenous Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 24(1): 163-168, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28939454
18.
Allogeneic Stem Cell Transplantation versus Tyrosine Kinase Inhibitors Combined with Chemotherapy in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.
Biol Blood Marrow Transplant
; 24(4): 741-750, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29247779
19.
Prevalence and outcomes of uncommon BCR-ABL1 fusion transcripts in patients with chronic myeloid leukaemia: data from a single centre.
Br J Haematol
; 182(5): 693-700, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29974949
20.
Interferon-α Is Effective for Treatment of Minimal Residual Disease in Patients with t(8;21) Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation: Results of a Prospective Registry Study.
Oncologist
; 23(11): 1349-1357, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30076280